Summary | |
---|---|
Symbol | RORC |
Name | RAR-related orphan receptor C |
Aliases | RZRG; RORG; NR1F3; TOR; RZR-GAMMA; RAR-related orphan nuclear receptor variant 2; nuclear receptor RZR-gamma ...... |
Chromosomal Location | 1q21 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Basic function annotation. > Subcellular Location, Domain and Function > Gene Ontology > KEGG and Reactome Pathway |
Subcellular Location | Nucleus |
Domain |
PF00104 Ligand-binding domain of nuclear hormone receptor PF00105 Zinc finger |
Function |
Nuclear receptor that binds DNA as a monomer to ROR response elements (RORE) containing a single core motif half-site 5'-AGGTCA-3' preceded by a short A-T-rich sequence. Key regulator of cellular differentiation, immunity, peripheral circadian rhythm as well as lipid, steroid, xenobiotics and glucose metabolism (PubMed:19381306, PubMed:19965867, PubMed:22789990, PubMed:26160376, PubMed:20203100). Considered to have intrinsic transcriptional activity, have some natural ligands like oxysterols that act as agonists (25-hydroxycholesterol) or inverse agonists (7-oxygenated sterols), enhancing or repressing the transcriptional activity, respectively (PubMed:19965867, PubMed:22789990). Recruits distinct combinations of cofactors to target gene regulatory regions to modulate their transcriptional expression, depending on the tissue, time and promoter contexts. Regulates the circadian expression of clock genes such as CRY1, ARNTL/BMAL1 and NR1D1 in peripheral tissues and in a tissue-selective manner. Competes with NR1D1 for binding to their shared DNA response element on some clock genes such as ARNTL/BMAL1, CRY1 and NR1D1 itself, resulting in NR1D1-mediated repression or RORC-mediated activation of the expression, leading to the circadian pattern of clock genes expression. Therefore influences the period length and stability of the clock. Involved in the regulation of the rhythmic expression of genes involved in glucose and lipid metabolism, including PLIN2 and AVPR1A (PubMed:19965867). Negative regulator of adipocyte differentiation through the regulation of early phase genes expression, such as MMP3. Controls adipogenesis as well as adipocyte size and modulates insulin sensitivity in obesity. In liver, has specific and redundant functions with RORA as positive or negative modulator of expression of genes encoding phase I and Phase II proteins involved in the metabolism of lipids, steroids and xenobiotics, such as SULT1E1. Also plays also a role in the regulation of hepatocyte glucose metabolism through the regulation of G6PC and PCK1 (PubMed:19965867). Regulates the rhythmic expression of PROX1 and promotes its nuclear localization (PubMed:19381306, PubMed:19965867, PubMed:22789990, PubMed:26160376, PubMed:20203100). Plays an indispensable role in the induction of IFN-gamma dependent anti-mycobacterial systemic immunity (PubMed:26160376). ; FUNCTION: Isoform 2: Essential for thymopoiesis and the development of several secondary lymphoid tissues, including lymph nodes and Peyer's patches. Required for the generation of LTi (lymphoid tissue inducer) cells. Regulates thymocyte survival through DNA-binding on ROREs of target gene promoter regions and recruitment of coactivaros via the AF-2. Also plays a key role, downstream of IL6 and TGFB and synergistically with RORA, for lineage specification of uncommitted CD4(+) T-helper (T(H)) cells into T(H)17 cells, antagonizing the T(H)1 program. Probably regulates IL17 and IL17F expression on T(H) by binding to the essential enhancer conserved non-coding sequence 2 (CNS2) in the IL17-IL17F locus. May also play a role in the pre-TCR activation cascade leading to the maturation of alpha/beta T-cells and may participate in the regulation of DNA accessibility in the TCR-J(alpha) locus. |
Biological Process |
GO:0002250 adaptive immune response GO:0002263 cell activation involved in immune response GO:0002285 lymphocyte activation involved in immune response GO:0002286 T cell activation involved in immune response GO:0002287 alpha-beta T cell activation involved in immune response GO:0002292 T cell differentiation involved in immune response GO:0002293 alpha-beta T cell differentiation involved in immune response GO:0002294 CD4-positive, alpha-beta T cell differentiation involved in immune response GO:0002366 leukocyte activation involved in immune response GO:0002460 adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains GO:0002521 leukocyte differentiation GO:0005996 monosaccharide metabolic process GO:0006006 glucose metabolic process GO:0006109 regulation of carbohydrate metabolic process GO:0006352 DNA-templated transcription, initiation GO:0006367 transcription initiation from RNA polymerase II promoter GO:0006805 xenobiotic metabolic process GO:0007159 leukocyte cell-cell adhesion GO:0007623 circadian rhythm GO:0008202 steroid metabolic process GO:0009410 response to xenobiotic stimulus GO:0009755 hormone-mediated signaling pathway GO:0010675 regulation of cellular carbohydrate metabolic process GO:0010906 regulation of glucose metabolic process GO:0019216 regulation of lipid metabolic process GO:0019218 regulation of steroid metabolic process GO:0019318 hexose metabolic process GO:0030098 lymphocyte differentiation GO:0030217 T cell differentiation GO:0030522 intracellular receptor signaling pathway GO:0032922 circadian regulation of gene expression GO:0035710 CD4-positive, alpha-beta T cell activation GO:0036314 response to sterol GO:0036315 cellular response to sterol GO:0042093 T-helper cell differentiation GO:0042110 T cell activation GO:0042752 regulation of circadian rhythm GO:0042753 positive regulation of circadian rhythm GO:0043367 CD4-positive, alpha-beta T cell differentiation GO:0043401 steroid hormone mediated signaling pathway GO:0044262 cellular carbohydrate metabolic process GO:0044723 single-organism carbohydrate metabolic process GO:0045165 cell fate commitment GO:0045444 fat cell differentiation GO:0045598 regulation of fat cell differentiation GO:0046631 alpha-beta T cell activation GO:0046632 alpha-beta T cell differentiation GO:0048511 rhythmic process GO:0048545 response to steroid hormone GO:0060612 adipose tissue development GO:0060850 regulation of transcription involved in cell fate commitment GO:0061448 connective tissue development GO:0070486 leukocyte aggregation GO:0070489 T cell aggregation GO:0071383 cellular response to steroid hormone stimulus GO:0071396 cellular response to lipid GO:0071407 cellular response to organic cyclic compound GO:0071466 cellular response to xenobiotic stimulus GO:0071593 lymphocyte aggregation GO:0072538 T-helper 17 type immune response GO:0072539 T-helper 17 cell differentiation |
Molecular Function |
GO:0003707 steroid hormone receptor activity GO:0004879 RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding GO:0005496 steroid binding GO:0008142 oxysterol binding GO:0032934 sterol binding GO:0098531 transcription factor activity, direct ligand regulated sequence-specific DNA binding |
Cellular Component | - |
KEGG |
hsa04710 Circadian rhythm |
Reactome |
R-HSA-1280215: Cytokine Signaling in Immune system R-HSA-74160: Gene Expression R-HSA-212436: Generic Transcription Pathway R-HSA-168256: Immune System R-HSA-6785807: Interleukin-4 and 13 signaling R-HSA-383280: Nuclear Receptor transcription pathway R-HSA-449147: Signaling by Interleukins |
Summary | |
---|---|
Symbol | RORC |
Name | RAR-related orphan receptor C |
Aliases | RZRG; RORG; NR1F3; TOR; RZR-GAMMA; RAR-related orphan nuclear receptor variant 2; nuclear receptor RZR-gamma ...... |
Chromosomal Location | 1q21 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | Literatures that report relations between RORC and anti-tumor immunity. The specific mechanism were also collected if the literature reports that a gene specifically promotes or inhibits the infiltration or function of T/NK cells. |
Literatures describing the relation between RORC and anti-tumor immunity in human cancer.
|
Summary | |
---|---|
Symbol | RORC |
Name | RAR-related orphan receptor C |
Aliases | RZRG; RORG; NR1F3; TOR; RZR-GAMMA; RAR-related orphan nuclear receptor variant 2; nuclear receptor RZR-gamma ...... |
Chromosomal Location | 1q21 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | High-throughput screening data (e.g. CRISPR-Cas9, shRNA and RNAi) for T cell-mediated killing. Genetic screen techniques can identify mechanisms of tumor cell resistance (e.g., PTPN2) and sensitivity (e.g., APLNR) to killing by cytotoxic T cells, the central effectors of anti-tumor immunity. After comprehensively searching, eight groups of screening data sets were collected in the current database. In this tab, users can check whether their selected genes cause resistance or increase sensitivity to T cell-mediated killing in various data sets. |
> High-throughput Screening
[ TOP ]
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Statistical results of RORC in screening data sets for detecting immune reponses.
|
Summary | |
---|---|
Symbol | RORC |
Name | RAR-related orphan receptor C |
Aliases | RZRG; RORG; NR1F3; TOR; RZR-GAMMA; RAR-related orphan nuclear receptor variant 2; nuclear receptor RZR-gamma ...... |
Chromosomal Location | 1q21 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Transcriptomic and genomic profiling of pre-treated tumor biopsies from responders and non-responders to immunotherapy. These data were used to identify signatures and mechanisms of response to checkpoint blockade (e.g., anti-PDL1 and anti-PD1). One example is that mutations in the gene PBRM1 benefit clinical survival of patients with clear cell renal cell carcinoma. After comprehensively searching, we collected 5 and 6 of transcriptomic and genomic data sets, respectively. In this tab, users can check whether their selected genes have significant difference of expression or mutation between responders and non-responders in various data sets. > Expression difference between responders and non-responders > Mutation difference between responders and non-responders |
Points in the above scatter plot represent the expression difference of RORC in various data sets.
|
Points in the above scatter plot represent the mutation difference of RORC in various data sets.
|
Summary | |
---|---|
Symbol | RORC |
Name | RAR-related orphan receptor C |
Aliases | RZRG; RORG; NR1F3; TOR; RZR-GAMMA; RAR-related orphan nuclear receptor variant 2; nuclear receptor RZR-gamma ...... |
Chromosomal Location | 1q21 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between abundance of tumor-infiltrating lymphocytes (TILs) and expression, copy number, methylation, or mutation of RORC. The immune-related signatures of 28 TIL types from Charoentong's study, which can be viewed in the download page. For each cancer type, the relative abundance of TILs were inferred by using gene set variation analysis (GSVA) based on gene expression profile. In this tab, users can examine which kinds of TILs might be regulated by the current gene. |
Summary | |
---|---|
Symbol | RORC |
Name | RAR-related orphan receptor C |
Aliases | RZRG; RORG; NR1F3; TOR; RZR-GAMMA; RAR-related orphan nuclear receptor variant 2; nuclear receptor RZR-gamma ...... |
Chromosomal Location | 1q21 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between three kinds of immunomodulators and expression, copy number, methylation, or mutation of RORC. These immunomo-dulators were collected from Charoentong's study. In this tab, users can examine which immunomodulators might be regulated by RORC. > Immunoinhibitor > Immunostimulator > MHC molecule |
Summary | |
---|---|
Symbol | RORC |
Name | RAR-related orphan receptor C |
Aliases | RZRG; RORG; NR1F3; TOR; RZR-GAMMA; RAR-related orphan nuclear receptor variant 2; nuclear receptor RZR-gamma ...... |
Chromosomal Location | 1q21 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between chemokines (or receptors) and expression, copy number, methylation, or mutation of RORC. In this tab, users can examine which chemokines (or receptors) might be regulated by the current gene. > Chemokine > Receptor |
Summary | |
---|---|
Symbol | RORC |
Name | RAR-related orphan receptor C |
Aliases | RZRG; RORG; NR1F3; TOR; RZR-GAMMA; RAR-related orphan nuclear receptor variant 2; nuclear receptor RZR-gamma ...... |
Chromosomal Location | 1q21 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Distribution of RORC expression across immune and molecular subtypes. > Immune subtype > Molecular subtype |
Summary | |
---|---|
Symbol | RORC |
Name | RAR-related orphan receptor C |
Aliases | RZRG; RORG; NR1F3; TOR; RZR-GAMMA; RAR-related orphan nuclear receptor variant 2; nuclear receptor RZR-gamma ...... |
Chromosomal Location | 1q21 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Associations between RORC and clinical features. > Overall survival analysis > Cancer stage > Tumor grade |
Summary | |
---|---|
Symbol | RORC |
Name | RAR-related orphan receptor C |
Aliases | RZRG; RORG; NR1F3; TOR; RZR-GAMMA; RAR-related orphan nuclear receptor variant 2; nuclear receptor RZR-gamma ...... |
Chromosomal Location | 1q21 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | Drugs targeting RORC collected from DrugBank database. |
There is no record. |